This prospective study was done in National Institute of Cardiovascular Diseases, Dhaka, Bangladesh during the period of January 2004 to January2005 to see the effectiveness and safety profile of percutaneous coronary interventions in patients with coronary artery disease. 100 patients with male 90 percent and female 10 percent undergo percutaneous coronary intervention in our unit during this period. Indication of percutaneous coronary interventions were chronic stable angina with stress test positive in 20 percent cases, unstable angina with prior myocardial infarction in 30 percent cases, unstable angina without prior myocardial infarction in 20percent cases, acute inferior myocardial infarction with post myocardial infarction angina in 20 percent cases and acute anterior myocardial infarction with post myocardial infarction angina in 10 percent cases. Angiographic diagnosis of the patients were single vessel disease in 70 percent cases , double vessel disease in 24 percent cases and triple vessel disease in 11 percent cases. Total number of disease coronary arteries was 146 and 125 lesions were treated. Out of 125, 120 lesions were treated with percuteneous transluminal coronary angioplasty with stenting and 5 lesions with plain percuteneous transluminal coronary angioplasty .Total occlusion was treated in 7 cases. Mean diameter of stent used was 3.02 ± 0.42 mm. Patients were discharged by three to four days of the procedure with improved clinical conditions.Residual stenosis after deploying of stent was less than l 0 percent. Our angiographic success rate was 98 percent, procedural success 96 percent and clinical success 95 percent. Failed percuteneous transluminal coronary angioplasty in 2 cases all of them were chronic total occlusion. One patient died on third day of the procedure due to ventricular asystole, he was a patient of triple vessel disease. Following procedure, course of the patients were uneventful. In the field of maagement of coronary artery disease percutaneous coronary intervention is the internationally recognized standard treatment worldwide for more than last 2 decades. From our result it is found that in most of the indicated cases of PCI can be done efficiently with very minimum rate of failure & complication.
Introduction
Coronary angioplasty was first introduced by Andreas Gruentzig in 1977 as a non-surgical method for coronary arterial revascularization 1 . Fundamentally the technique involved advancing a balloon tipped catheter to an area of coronary narrowing, inflating the balloon & then removing the catheter following deflation. Early reports demonstrated that balloon angioplasty could reduce the severity of coronary stenosis & diminish or eliminate objective & subjective manifestations of ischemia 2,3,4 . Although angioplasty was clearly feasible & effective, the scope of coronary disease to be treated was quite narrow. Also, angioplasty could result in sudden arterial occlusion & subsequently myocardial infarction (MI), immediate access to coronary bypass surgery was essential 5 . Day by day with experience & time, the cognitive & technical aspects as much as the equipment used to perform angioplasty became more refined. Now coronary angioplasty could be applied to broad groups of coronary patients with higher rate of success & lower rates of complications when compared to initial experience 6,7 . Percutaneous coronary interventions (PCI) 
Procedure
All the procedures were done through right femoral arterial approach using 7F guiding catheters most frequently Judkins in some cases with extra back up catheters, with premedication of aspirin, clopidogrel, anti-ischemic therapy and statin. Beginning of procedure a bolus of 10,000 unit heparin given & activated clotting time (ACT) was done after 10 minutes & it was maintained around 300 during the whole procedure by giving 5000 unit heparin hourly. 90% of the lesion was predilated by balloons before deploying stents. Balloon expandable stents were used in all the cases. Femoral sheaths were removed within 4-6 hours of the procedure. In all cases post procedure heparin used. Clopidogrel was used in all patients. During hospital discharge all patients were prescribed with aspirin 150 mg daily, clopidogrel 150 mg daily, anti ischemic therapy and statin .
Results 100 consecutive patients of symptomatic coronary artery disease underwent percutaneous coronary interventions in our unit were selected for the present study. The age range of the patients was from 28-70 years with a mean of 50.59 ±7.69 yrs. 90 patients were male and 10 patients were female with a male female ratio of 9:1. Left ventricular ejection fraction was as low as 35% with a mean of 47 ± 10.5%.Mean Coronary artery diameter was 3.03 ± 0.53 mm & no stent was deployed in vessels caliber less than 2.5 mm, lesion > 38 mm, in cases of extreme tortusity, thrombus at the site of the lesion. The risk factors of the study population were smoking in 65% cases, hypertension in 52% cases, diabetes mellitus in 34% cases, hyperlipidemia in 30% cases,and positive family history of ischemic heart disease in 25% cases (Table-1 ). Table -5 showed, 122 stents were used in the study population. Mean diameter of the stent was 2.70 ± 0.53 mm, majority of the stents were 3.0 mm diameter. Length of the stents was within the range of 10-18mm.Majority stents were bare metal stent (70%). Table-7) . One patient died on 3rd day of the procedure; he was a patient of triple vessel disease. Following procedure, course of the patients were uneventful. Patients were discharged by three to four days of the procedure with improved clinical conditions 
Table8: Results of PCI of the study population Discussion

Disucussion
From this result it is found that most of the patients are male (90%), common risk factors are smoking (65%) and hypertension (52%).80% had myocardial infraction either acute or old. Angiographic diagnosis of the study population showed single vessel disease was common (65 %). Total numbers of diseased coronary artery were 146.120 lesions were treated with percuteneous transluminal coronary angioplasty with stenting .Rest of the lesions were treated with plain percuteneous transluminal coronary angioplasty. 7 cases had total occlusion of the coronary artery. 122 stents were used in the study population, majority of the stents were 3.0 mm diameter. Length of the stents was within the range of 10-18mm. Most of the stents were bare metal stent(70% 12 here showed angiographic success rate was 96% with procedural success 94% and clinical success 90%. Failed percuteneous transluminal coronary angioplasty was in 4% cases, all of which were chronic total occlusions. 1% patient developed acute left ventricular failure and 1% in hospital mortality. Both studies were compatible with our study.
Conclusion
Percutaneous coronary intervention is the recognized therapies in the management of coronary artery disease with mortality and morbidity benefit. Our result of percutaneous coronary intervention correlates well with the other studies here and abroad, though the study population is small. However the additional iatrogenic disease instent stenosis is one of the drawbacks of the percutaneous coronary intervention, it may be overcome to some extent with drug eluting stent. From this study it is found that in most of the indicated cases of percutaneous coronary intervention can be done efficiently with very minimum rate of failure & complication. So, percutaneous coronary interventions are the safe and effective procedure in the management of patients with coronary artery disease.
